×

Modified Release Formulation

  • US 20110150994A1
  • Filed: 02/28/2011
  • Published: 06/23/2011
  • Est. Priority Date: 02/10/2006
  • Status: Abandoned Application
First Claim
Patent Images

1. An extended release formulation comprising pramipexole or a pharmaceutically acceptable salt thereof having a reduced side effect profile when administered to a patient in terms of at least one condition selected from sleepiness and/or hallucinations and/or dizziness and/or headache and/or dyskinesia and/or obstipation and/or periphere oedema and/or nausea when compared to an immediate release formulation comprising pramipexole or a pharmaceutically acceptable salt thereof when the immediate release formulation is administered to the patient as often as needed to provide the same average blood plasma concentration of pramipexole in said patient as is achieved during the release period of the extended release formulation when the extended release formulation is administered once in the same period.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×